Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Neely

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.
Journal of the Pediatric Infectious Diseases Society|June 30, 2023
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)Thomas J Sferra, Tomas Merta, Michael Neely, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic RelationshipsMarc H Scheetz, Gwendolyn M Pais, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Scientific Reports|May 10, 2024
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cellsSean N Avedissian, Johid R Malik, Anthony T Podany, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.
Journal of the Pediatric Infectious Diseases Society|June 30, 2023
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)Thomas J Sferra, Tomas Merta, Michael Neely, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsMona Arab-Alameddine, Aurélie Fayet-Mello, Rubin Lubomirov, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic RelationshipsMarc H Scheetz, Gwendolyn M Pais, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Scientific Reports|May 10, 2024
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cellsSean N Avedissian, Johid R Malik, Anthony T Podany, et al.
Pageof 10